
105.88 Delayed Data As of Sep 25 | ![]() Today’s Change | 85.29 Today|||52-Week Range 119.65 | -4.57% Year-to-Date |
Previous close | 105.84 |
Today’s open | 106.21 |
Day’s range | 105.13 - 106.24 |
Volume | 100 |
Average volume (3 months) | 7,263,771 |
Market cap | $269.8B |
Earnings growth (last year) | +11.18% |
Earnings growth (this year) | -58.25% |
Earnings growth (next 5 years) | +7.72% |
Revenue growth (last year) | +19.56% |
P/E ratio | 86.8 |
Price/Sales | 4.82 |
Price/Book | 5.87 |
Today’s change | Today’s % change | |
---|---|---|
ABBVAbbVie | +0.05 | +0.03% |
NONOFNovo Nordisk | -0.86 | -0.92% |
AZNAstraZeneca | +1.11 | +1.64% |
NVSNovartis | +0.67 | +0.66% |
Next reporting date | October 26, 2023 |
EPS forecast (this quarter) | $1.96 |
Annual revenue (last year) | $58.5B |
Annual profit (last year) | $14.5B |
Net profit margin | 24.83% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |